Table of Contents

company-logo

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Qualigen Therapeutics Dividend Announcement

• Qualigen Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Qualigen Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Qualigen Therapeutics Dividend History

Qualigen Therapeutics Dividend Yield

Qualigen Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Qualigen Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Qualigen Therapeutics Financial Ratios

P/E ratio-0.24
PEG ratio-0.00
P/B ratio-0.86
ROE261.41%
Payout ratio0.00%
Current ratio0.52
Quick ratio0.52
Cash Ratio0.09

Qualigen Therapeutics Dividend FAQ

Does Qualigen Therapeutics stock pay dividends?
Qualigen Therapeutics does not currently pay dividends to its shareholders.
Has Qualigen Therapeutics ever paid a dividend?
No, Qualigen Therapeutics has no a history of paying dividends to its shareholders. Qualigen Therapeutics is not known for its dividend payments.
Why doesn't Qualigen Therapeutics pay dividends?
There are several potential reasons why Qualigen Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Qualigen Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Qualigen Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Qualigen Therapeutics a dividend aristocrat?
Qualigen Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Qualigen Therapeutics a dividend king?
Qualigen Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Qualigen Therapeutics a dividend stock?
No, Qualigen Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Qualigen Therapeutics stocks?
To buy Qualigen Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Qualigen Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.